Voximetry is an early commercial-stage healthcare technology and services company specializing in the commercialization of complex algorithms on high-speed Graphic Processing Units (GPUs). Currently focused on radiation transport science and voxel-level dosimetry, Voximetry is pioneering patient-specific treatment planning in advanced-stage cancer patients. Voximetry leverages intellectual property developed at the University of Wisconsin-Madison, which has a rich history of fostering successful biotechnology companies.